Autolus Therapeutics plc Working Capital to Net Assets Ratio
Autolus Therapeutics plc working capital to net assets ratio. Autolus Therapeutics plc (6A3A) has a Working Capital to Net Assets ratio of 357.2% as of June 2026. Working capital of €267.30 Million (current assets of €336.09 Million minus current liabilities of €68.79 Million) is measured against net assets of €74.84 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Autolus Therapeutics plc (6A3A) tangible equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Autolus Therapeutics plc (2017–2025)
Working capital to net assets ratio of Autolus Therapeutics plc from 2017 to 2025. This chart shows how Autolus Therapeutics plc's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2017 to 2025. As of June 2026, the ratio stands at 357.2%, reflecting working capital of €267.30 Million against net assets of €74.84 Million EUR. See Autolus Therapeutics plc (6A3A) defensive interval to measure how many days the company can operate on defensive assets alone.
Autolus Therapeutics plc Working Capital to Net Assets Ratio by Year (2017–2025)
Autolus Therapeutics plc working capital to net assets ratio by year from 2017 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Autolus Therapeutics plc from 2017 to 2025, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see balance sheet size of Autolus Therapeutics plc.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 203.5% | €362.48 Million | €178.13 Million | €435.92 Million | €73.44 Million | ▲ +63.0 pp |
| 2024 | 140.5% | €600.19 Million | €427.32 Million | €660.93 Million | €60.74 Million | ▼ -66.4 pp |
| 2023 | 206.8% | €230.56 Million | €111.47 Million | €275.30 Million | €44.74 Million | ▲ +79.8 pp |
| 2022 | 127.0% | €379.40 Million | €298.67 Million | €425.77 Million | €46.37 Million | ▲ +25.4 pp |
| 2021 | 101.6% | €318.40 Million | €313.32 Million | €346.95 Million | €28.55 Million | ▲ +23.8 pp |
| 2020 | 77.8% | €163.35 Million | €210.03 Million | €196.98 Million | €33.63 Million | ▼ -10.2 pp |
| 2019 | 88.0% | €224.27 Million | €254.84 Million | €249.26 Million | €24.98 Million | ▲ +5.1 pp |
| 2018 | 82.9% | €211.89 Million | €255.47 Million | €232.97 Million | €21.08 Million | ▼ -13.4 pp |
| 2017 | 96.4% | €137.45 Million | €142.60 Million | €142.48 Million | €5.03 Million | — |